| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 1998;29:2254-2260.)
© 1998 American Heart Association, Inc.
Original Contributions |
Neurometabolite Markers of Cerebral Injury in the Antiphospholipid Antibody Syndrome of Systemic Lupus Erythematosus
From the Clinical and Magnetic Resonance Research System (A.S., W.L.S., W.M.B.) and the Departments of Internal Medicine (W.L.S., J.D.), Biostatistics Section of Family and Community Medicine (C.A.S.), and Neurosciences (W.M.B.), The University of New Mexico Health Sciences Center, Albuquerque, NM.
Background and Purpose—To determine the neurometabolic patterns of brain injury in systemic lupus erythematosus with antiphospholipid antibody syndrome (SLE-aPLS).
Methods—Forty-nine SLE patients (12 SLE-aPLS) and 23 control subjects were studied using magnetic resonance imaging and spectroscopy. N-Acetylaspartate/creatine (NAA/Cre) and choline/Cre (Cho/Cre) were measured in normal-appearing tissue. IgG and IgM antiphospholipid antibodies (aPL) were measured by enzyme-linked immunosorbent assay.
Results—Stroke, epilepsy, and elevated IgG-aPL were more common in SLE-aPLS patients than in SLE patients (P<0.001). NAA/Cre was lower (P<0.05) and Cho/Cre higher (P<0.001) in SLE-aPLS patients than in SLE patients without aPLS. Regression models showed NAA/Cre was most related to injury seen by imaging (P<0.01), disease duration (P<0.05), and prior neuropsychiatric SLE (NPSLE) (P=0.07). Reduced NAA/Cre was more closely related to IgG-aPL (P<0.01) than the presence of stroke or aPLS. When adjusted for all factors, Cho/Cre was most associated with the presence of aPLS (P=0.05).
Conclusions—SLE and SLE-aPLS are actually a clinical continuum describing brain injury in SLE, with SLE-aPLS being characterized by increased aPL, NPSLE, stroke, epilepsy, and disturbed neurochemistry. An elevated IgG-aPL level is a potent risk factor for brain injury as measured by NAA/Cre in SLE that is independent of stroke and aPLS. However, thrombotic phenomena and the presence of aPL (aPLS) are most closely associated with increased Cho/Cre in SLE. These results suggest that aPLs exacerbate SLE, resulting in increased thrombotic and nonthrombotic brain injuries. Spectroscopy detects brain injury in SLE and may permit better understanding of the neurological consequences of SLE and SLE-aPLS.
Key Words: antiphospholipid syndrome • brain injuries • lupus • magnetic resonance • neurochemistry • spectroscopy
This article has been cited by other articles:
 |
|
 |
|
  S. Appenzeller, L.M. Li, L.T.L. Costallat, and F. Cendes Neurometabolic changes in normal white matter may predict appearance of hyperintense lesions in systemic lupus erythematosus Lupus, December 1, 2007; 16(12): 963 - 971. [Abstract] [PDF]
|
|
|
|
 |
|
 G Castellino, M Govoni, M Padovan, P Colamussi, M Borrelli, and F Trotta Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up Ann Rheum Dis, July 1, 2005; 64(7): 1022 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Govoni, G Castellino, M Padovan, M Borrelli, and F Trotta Recent advances and future perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus Lupus, March 1, 2004; 13(3): 149 - 158. [Abstract] [PDF]
|
|
|
|
|
|
P L Peterson, F A Howe, C A Clark, and J S Axford Quantitative magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus Lupus, December 1, 2003; 12(12): 897 - 902. [Abstract] [PDF]
|
|
|
|
|
|
A Katzav, J Chapman, and Y Shoenfeld CNS dysfunction in the antiphospholipid syndrome Lupus, December 1, 2003; 12(12): 903 - 907. [Abstract] [PDF]
|
|
|
|
|
|
R L Brey, J Chapman, S R Levine, G Ruiz-Irastorza, R H. Derksen, M Khamashta, and Y Shoenfeld Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002 Lupus, July 1, 2003; 12(7): 508 - 513. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Sanna, M. L. Bertolaccini, M. J. Cuadrado, M. A. Khamashta, and G. R. V. Hughes Central nervous system involvement in the antiphospholipid (Hughes) syndrome Rheumatology, February 1, 2003; 42(2): 200 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J S Axford, F A Howe, C Heron, and J R Griffiths Sensitivity of quantitative 1H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus Ann Rheum Dis, February 1, 2001; 60(2): 106 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J PALACE and B LANG Epilepsy: an autoimmune disease? J. Neurol. Neurosurg. Psychiatry, December 1, 2000; 69(6): 711 - 714. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Aarli Epilepsy and the Immune System Arch Neurol, December 1, 2000; 57(12): 1689 - 1692. [Abstract] [Full Text] [PDF]
|
|